Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

• Status: Completed
• Trial end date: 2015-11-16
• Target enrollment: 0
• Participant gender: All

Summary

This study is conducted in Europe. The aim of this study is to investigate Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in daily Practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novo Nordisk A/S
• Treatments: Liraglutide

Criteria

Inclusion Criteria:

• Subjects of age above 18 years as per Victoza® SmPC par.4.2 and 5.1 diagnosed with type 2 diabetes receiving the first prescription of liraglutide in 2011

Exclusion Criteria:

• None. Available data from all eligible patients for each center, will be included